期刊文献+

卡维地洛治疗儿童心血管系统疾病的研究进展 被引量:4

Mechanism of Carvedilol in Treatment of Cardiovascular Disease in Children
下载PDF
导出
摘要 卡维地洛(carvedilol)是一种新型的非选择性肾上腺素能受体阻滞剂,具有β受体和α受体双重阻滞、调节细胞因子、抗氧化、抗心脏重构和抗心律失常等多方面的作用,无内在拟交感活性,避免了反射性交感神经兴奋所引起的周围血管收缩及外周阻力增加,通过减轻心肌炎症,延缓并逆转心室重构,改善血流动力学,改善预后。目前关于卡维地洛治疗或干预儿童病毒性心肌炎、扩张型心肌病、心律失常已逐渐受到重视。现对卡维地洛治疗儿童心血管系统疾病研究进展做一综述。 Carvedilol can inhibit β-receptor and α-receptor,regulate cytokine,and has antioxidant,antiremodeling and antiarrhythmia actions.Carvedilol is currently the treatment,or intervention,used for children with viral myocarditis,dilated cardiomyopathy,and cardiac arrhythmia.This paper reviews the mechanism of carvedilol in patients,particularly children,with cardiovascular diseases.
出处 《心血管病学进展》 CAS 2011年第4期607-609,共3页 Advances in Cardiovascular Diseases
关键词 卡维地洛 儿童心血管系统疾病 研究进展 carvedilol children with cardiovascular diseases research progress
  • 相关文献

参考文献37

  • 1李学文,华琦.卡维地洛药理作用机制研究进展[J].实用医学杂志,2005,21(11):1233-1235. 被引量:21
  • 2Molenaar P, Christ T, Ravens U, et al. Carvedilol blocks beta 2- more than be- ta 1-adrenoceptors in human heart [ J]. Cardiovasc Res, 2006,69 (1):128- 139.
  • 3Chakraborty S, Shukla D, Mishra B, et al. Clinical updates on carvedilol: a first choice beta-blocker in the treatment of cardiovascular diseases [ J ]. Expert Opin Drug Metab Toxicol,2010,6(2) :237-250.
  • 4Tschope C, Westermann D, Steendijk P, et al. Hemodynamic characterization of left ventricular function in experimental coxsackieviral myocardifis : effets of caredilol and metoprolol [ J ]. Eur J Phannacol,2004,491 ( 2/3 ) : 173 - 179.
  • 5Pauschinger M, Rutschow S, Chandrasekharan K, et aL Carvedilol improves left ventricular function in murine coxsackievirus induced acute myocalxlifis asso- ciation with reduced myocardial intedeukin-I beta and MMP-8 expression and a modulated immune response[J]. EurJ Heart Fail,2005,7(4) :444-452.
  • 6Li B, Liao YtI, Cheng X, et ah Effects of carvedilol on cm'diac cytokines ex- pression and remodeling in rat with acute myocardial infarction [ J ]. Int J Cardiol,2006,111 (2) :247-255.
  • 7Calabrcse F, Carturan E, Chimenti C, et ah Over expression of tumor necrosis factor (TNF) alpha and TNF alpha receptor 1 in human viral myocarditis: clini- copathologic correlations [ J ]. Mod Pathol, 2004,17 ( 9 ) : 1108 - 1118.
  • 8Nishio R, Shioi T, Sasayama S, et ah Carvedilol increases the production of'in- terleukin-12 and interferon-3' and improves the survival of mice infected with the eneephalomyocarditis vinas [ J ]. J Am Coil Cardiol, 2003,41 (2) :340-345.
  • 9Kyoi S, Otani H, Matsuhisa S, et ah Opposing effect of p38 MAP kinase and JNK inhibitors on the development of heart failure in the ealxtiomyopathic ham- ster [J]. Cardiovasc Res,2006,69(4) :888-898.
  • 10Hirasawa K, Kim A, Han HS, et al. Effect of p38 mitogen activated protein kinase on the replication of encephalomyocarditis virus [ J ]. J Virol, 2003,77 (10) :5649-5656.

二级参考文献70

共引文献124

同被引文献52

  • 1李勇,诸骏仁.β受体阻滞剂治疗慢性心力衰竭——COMET研究的意义[J].中华心血管病杂志,2004,32(5):466-468. 被引量:50
  • 2李学文,华琦.卡维地洛药理作用机制研究进展[J].实用医学杂志,2005,21(11):1233-1235. 被引量:21
  • 3钱永如.小儿慢性心力衰竭治疗进展[J].实用儿科临床杂志,2006,21(18):1202-1204. 被引量:5
  • 4Chattopadhyay S, Yamashita M, Zhang Y, et al. The IRF -3/ Bax mediated apoptotic pathway activated by viral cytoplasmic RNA and DNA, inhibits virus replication [J]. J Virol, 2011,85 (8) :3708 -3716.
  • 5Zorc - Pleskovic R, Alibegovib A, Zorc M, et al. Apoptosis of cardiomyocytes in myoearditis [ J ]. Folia Biol ( Praha ) , 2006,52 (1 -2) :6 -9.
  • 6Yue - Chun L, Li - Sha G ,Jiang - Hua R ,etal. Protective effects of carvcdilol in murine model with the coxsackievirus B3 - induced viral myocarditis [J]. J Cardiovasc Pharmacol, 2008, 51 (1) :92 -98.
  • 7Nishio R, Shioi T, Sasayama S, et al. Carvedilol increases the production of interleukin - 12 and interferon - γ and improves the survival of mice infected with the encephalomyocarditis virus [ J ]. J Am Coil Cardiol, 2003,41 (2) :340 - 345.
  • 8Li YC, Ge LS, Yang PL, et al. Carvedilol treatment ameliorates acute coxsackievirus B3 - induced myocarditis associated with ox- idative stress reduction [ J]. Eur J Pharmacol, 2010,640 ( 1 - 3) :112 -116.
  • 9Gao X, He X, Luo B, et al. Angiotensin I1 increases col- lagen espression Via transforming growth factor-betal and excracellular signal-regulated Kinase in cardiac fibroblasts [J]. Eur J Pharmacol, 2009, 606:115 - 120.
  • 10Massague J. Integration of Smad and MAPK pathways: a link and a linker revised [J]. Genes Dev, 2003, 17. 2993 - 2997.

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部